Physician profile
Hanh Le
NPI 1023098613
$1,961.07
in general payments reported to CMS, 2019-2025
17 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $112 · 2021: $238 · 2022: $114 · 2023: $40.52 · 2024: $140 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $417.10 | 2020-2025 | |
| Tarsus Pharmaceuticals, INC. | $399.91 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $200.41 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $155.65 | 2020-2025 | Rocklatan, Dailies Total1, Total30 |
| Johnson & Johnson Vision Care, INC. | $121.85 | 2025 | Acuvue |
| Eyevance Pharmaceuticals LLC | $117.59 | 2019-2021 | |
| Allergan, INC. | $110.24 | 2019 | |
| Aerie Pharmaceuticals, INC. | $97.95 | 2019-2021 | |
| Dompe US, INC. | $90.69 | 2022-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $56.34 | 2019-2021 | |
| Biotissue Holdings INC. | $42.68 | 2022-2025 | |
| Abbvie INC. | $40.14 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.52 | 2019-2020 | |
| Shire North American Group INC | $21.79 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $16.19 | 2022 | |
| Oyster Point Pharma, INC. | $13.62 | 2025 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanh Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.